Gene expression profiling enables the classification of breast cancer into distinct molecular subtypes with prognostic significance based upon histological grade and the status of estrogen receptor (ER), progesterone receptor (PgR), and HER2/neu expression (HER2 or ErbB2). Here, ERBB2 is linked to breast carcinoma.